Aguado DL, Pinero BP, Betancor L, Banales CE. Acyclovir in the treatment of laryngeal papillomatosis. Int J Ped Otorhinolaryngol l 99 l; 2 l: L 269-74.
Alberts OS, Coulthard SW, Meyskens FL. Regression of aggressive laryngeal papillomatosis with l 3-cis-rctinoic acid ( accutane ). J Biol Response Mod 1986; 5: 124-8.
Armstrong LR, Derkay CS, Reeves WC. Initial results from the National Registry for Juvenile-onset recurrent papillomatosis Arch otolaryngol Head Neck Surg 1999; 125: 743-48.
Avidano MA, Singleton GT. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1995; 112: 187-202.
Benjamin BN,Gatenby PA, Kitchen R, Harrison H, Cameron K, Basten A. Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Oto! Rhino! Laryngol 1988; 87: 376-80.
Bent JP, Porubsky ES. Recurrent respiratory papillomatosis. Insights in Otolaryngology 1993; 8: 1-8.
Derkay CS. Task force on recurrent respiratory papillomatosis. A preliminary report. Arch Otolaryngol Head Neck Surg l 995; 12 l: l 386-91.
Derkay CS, Faust RA. Recurrent respiratory papillomatosis. In: Cummings Otolaryngology Head & Neck surgery.-4 Ed.-Philadelphia: Elsvier Mosby, 2005; vol 4: 4370-86.
Eicher SA, Taylor-Cooley LO, Donovan OT. lsotretinoin therapy for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 1994; 120: 405-9.
Endres DR, Bauman NM, Burke D, Smith RJ. Acyclovir in the treatment of recurrent respiratory papillomatosis. Ann Otol Rhino! Laryngol 1994; 103: 301-5.
Gerein V, Lodemann E, Bell G, vonllberg C, Komhuber B. Results of long-term leucocyte interferon (alpha IFN) therapy using an individuÂally determined dose schedule in recurrent laryngeal papillomatosis. Klin Pediatr 1987; 199: 224-9.
Gere in V, Rastorguev E, Gere in J, Jecker P, Pfister H. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year foolow-up. Ann Otol Rhino! Laryngol 2005; 11, 4:463-71.
Haglund S, Lundquist P, Cantell K, Strander H. Interferon therapy in juvenile laryngeal papillomatosis Arch Otolaryngol 1981; l 07: 327-32.
Healy GB, Gelber RD, Trowbridge AL, ct al. Treatment of recurrent respiratory papillomatosis with human leucocyte interferon. Results of a multicenter randomized clinical trial N Engl J Med l 988; 319: 40 l-7.
Huang C, Ma WY, Dawson Ml, Rincon M, Flavell RA, Dong Z. Blocking activator protein-! activity, but not activating retinoic acid response element, is required for the antitumor effect of retinoic acid. Proc Natl Acad Sci USA 1997; 94: 5826- 30.
Kashima H, Leventhal B, Clark K, Cohen S, Dedo H, Donovan D, Fearon B, Gardiner L, Goepfert H, Lusk R. lnterferon-alpha-N l (Wellfcron) in juvenile-onset recurrent respiratory papillomatosis: resuts of a randomized study in twelve collaborative institutions. Laryngoscope l 988; 98: 334-40.
Kiroglu M, Cetik F, Soylu F, Abedi A, Aydogan Bet al. Acyclovir in the tratment of recurrent respiratory papillomatosis: a preliminary report. Am J Otolaryngol. 1994; 15: 212-14.
Leventhal BG, Kashima HK, Mounts P, Thurmond L, Chapman S, Buckley S, Wold D. Long-term response of recurrent respiratory papollomatosis to treatment with lymphblastoid interferon alfa-n I. Papilloma study group. N Engl J Med 1991; 325: 613-7.
Leventhal BG, Kashima HK, Weck PW, Mounts P, Whisnant JK, Clark KL, Cohen S, Dedo HH, Donovan DJ, Fearon BW. Randomized surgiÂcal adjuvant trial of interferon alfa-n l in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg 1988; 114: 1163-9.
Lusk RP, McCabe BF, Mixon JH. Three-year experience of trating recurrent respiratory papilloma with interferon. Ann Otol Rhino! Laryngol 1987; 96: 158-62.
McCabe BF,Klark KF. Interferon and laryngeal papillomas: the Iowa experience. Ann Otol Rhino! Laryngol 1983; 92: 2-7.
McGlennen RC, Adams GL, Lewis CM, Faras AJ, Ostrow RS. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis. Head Neck 1993; 15: 504-512.
Morrison GA, Evans JN. Juvenile respiratory papillomatosis: acyclovir reassessed. Int J Pediatr Otorhinolaryngol 1993; 26: l 93-7.
Morrison GA, Kotecha B, Evans JN. Ribavirin treatment for juvenile respiratory papillomatosis. J Laryngol Otol. 1993; l 07: 423-6.
Mullooly VM, Abramson AL, Steinberg BM, Horowitz MS. Clinical effects of alpha-interferon dose variation on laryngeal papilloma. Laryngoscope l 988; 98: l 324-29.
Newfield L, Goldsmith A, Bradlow L, Aubom K. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol. Anticancer Res 1993; 13: 337-342.
Pou AM, Rimel! FM, Jordan JA, Shoemaker DL, Johnson JT, Barna P, Post JC, Ehrlich GD. Adult respiratory papillomatosis: human Papillomavirus type and viral coinfcctions as predictors of prognosis. Ann Oto! Rhino! Laryngol l 995; l 04: 758-62.
Rimel! FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope 1997; l 07: 915-18.
Rosen CA, Woodson GE, Thomson JW, Hengesteg AP, Bradlow HL. Preliminary results of the use of indol-3-carbinol for recurrent respiraÂtory papillomatosis. Otolaryngol Head Neck Surg. I 988; 118: 8 I 0-815.
Shykhon M, Kuo M, Pearman K. Recurrent respiratory papillomatosis. Clin Otolaryngol, 2002; 27: 237-243.
Silverman DA, Pitman MJ. Current diagnostic and management trends for recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 2004; l 2: 532-7.
Walther EK, Herbcrhold C. Treatment of laryngotracheal papillomatosis with combined use of laser surgery and intralesional administration of alpha-interferon (Rofcron). Laryngorhinootology 1993; 72: 485-91.
Zenner HP, Kley W, Claros B, Lahas Z, Lobe LP,Pavelka R, Plath P, Ribari 0, Xiethammer D, Hirche H. Recombinant Interfcron-alpha-2c in laryngeal papillomatosis: preliminary results of a prospective multicentre trial. Oncology l 985; Suppl I; 42: l 5-l 8.
